Search research articles
Contact Us
Filters
Showing results (41-50 of 106) with videos related to
Page
of 11
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 25, 2017
Cognition and the course of prodromal Parkinson's disease
Daniel Weintraub, Lana M Chahine, Keith A Hawkins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 22, 2015
Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings
Lama M Chahine, Daniel Weintraub, Keith A Hawkins, et al.
Expert Review of Neurotherapeutics
|
November 5, 2016
Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective
Stuart H Isaacson, Stanley Fisher, Fiona Gupta, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 6, 2014
In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: 18F-MNI-659 and 18F-MNI-654
Olivier Barret, David Thomae, Adriana Tavares, et al.
Journal of Alzheimer'S Disease : JAD
|
January 28, 2020
Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission Tomography
Leonie Beyer, Matthias Brendel, Franziska Scheiwein, et al.
The Lancet. Neurology
|
April 13, 2011
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study
Henryk Barthel, Hermann-Josef Gertz, Stefan Dresel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Vijaya L Reddy, Jesse M Cedarbaum, John Seibyl, et al.
Neurology
|
January 9, 2015
Age dependence of brain β-amyloid deposition in Down syndrome: An [18F]florbetaben PET study
Danna Jennings, John Seibyl, Marwan Sabbagh, et al.
Neurobiology of Disease
|
April 30, 2018
Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study
Hua Wang, Anzari Atik, Tessandra Stewart, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 2, 2014
Adenosine 2A receptor occupancy by tozadenant and preladenant in rhesus monkeys
Olivier Barret, Jonas Hannestad, David Alagille, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 106) with videos related to
Sort By:
Page
of 11
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 25, 2017
Cognition and the course of prodromal Parkinson's disease
Daniel Weintraub, Lana M Chahine, Keith A Hawkins, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 22, 2015
Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings
Lama M Chahine, Daniel Weintraub, Keith A Hawkins, et al.
Expert Review of Neurotherapeutics
|
November 5, 2016
Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective
Stuart H Isaacson, Stanley Fisher, Fiona Gupta, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 6, 2014
In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: 18F-MNI-659 and 18F-MNI-654
Olivier Barret, David Thomae, Adriana Tavares, et al.
Journal of Alzheimer'S Disease : JAD
|
January 28, 2020
Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission Tomography
Leonie Beyer, Matthias Brendel, Franziska Scheiwein, et al.
The Lancet. Neurology
|
April 13, 2011
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study
Henryk Barthel, Hermann-Josef Gertz, Stefan Dresel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Vijaya L Reddy, Jesse M Cedarbaum, John Seibyl, et al.
Neurology
|
January 9, 2015
Age dependence of brain β-amyloid deposition in Down syndrome: An [18F]florbetaben PET study
Danna Jennings, John Seibyl, Marwan Sabbagh, et al.
Neurobiology of Disease
|
April 30, 2018
Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study
Hua Wang, Anzari Atik, Tessandra Stewart, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 2, 2014
Adenosine 2A receptor occupancy by tozadenant and preladenant in rhesus monkeys
Olivier Barret, Jonas Hannestad, David Alagille, et al.
Page
of 11